You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Bosentan
Bosentan is a medication used to treat pulmonary arterial hypertension (PAH), a condition characterized by high blood pressure in the arteries that supply the lungs. By relaxing and widening the blood vessels in the lungs, Bosentan helps to lower blood pressure, improve exercise capacity, and delay the progression of PAH. It belongs to a class of drugs known as endothelin receptor antagonists (ERAs), which work by blocking the effects of endothelin, a substance that causes blood vessels to constrict.
Oops! We currently don’t have the pricing information for this drug.
But we're continually improving our service to help you save and earn rebates on your medications. If your drug isn't listed on NiHowdy, you can still present your NiHowdy savings card at the pharmacy. We'll work to secure any eligible rebates for that drug and pass the savings back to you retroactively.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
Frequently Asked Questions
How long does it take for Bosentan to start working?
Bosentan may start to improve symptoms of pulmonary arterial hypertension within a few weeks of treatment, but it can take several months to achieve the full therapeutic effect. Regular follow-up with a healthcare provider is important to monitor progress.
Can I stop taking Bosentan if my symptoms improve?
No, you should not stop taking Bosentan without consulting your healthcare provider. Stopping the medication suddenly can lead to a worsening of pulmonary arterial hypertension and associated symptoms.
Is Bosentan safe to use during pregnancy?
No, Bosentan is not safe during pregnancy and can cause serious birth defects. Women of childbearing potential must use effective contraception and have regular pregnancy tests while taking Bosentan. If you become pregnant while taking Bosentan, contact your healthcare provider immediately.
What should I do if I miss a dose of Bosentan?
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at once.
Can Bosentan cause liver damage?
Yes, Bosentan can cause liver damage, which may be serious or even life-threatening. It is important to have regular liver function tests while taking Bosentan and to report any symptoms of liver problems, such as yellowing of the skin or eyes, dark urine, or unusual fatigue, to your healthcare provider immediately.
Comprehensive Drug Guide
How Does Bosentan Work?
Bosentan works by blocking the endothelin receptors (ETA and ETB) on the cells in blood vessels. Endothelin is a naturally occurring peptide that causes blood vessels to constrict and promotes the growth of smooth muscle cells in the walls of the blood vessels, which can lead to the narrowing of the arteries. By inhibiting endothelin's effects, Bosentan helps to relax and widen the blood vessels, thereby reducing the elevated blood pressure in the lungs and improving blood flow.
What is Bosentan Used For?
Treatment of Pulmonary Arterial Hypertension (PAH): To improve exercise ability and decrease the rate of clinical worsening in patients with WHO Group I PAH, including idiopathic or heritable PAH, and PAH associated with connective tissue diseases or congenital heart defects.
Common Dosages
Bosentan is available by prescription only and is not classified as a controlled substance. It is typically available in tablet form, with common strengths including 62.5 mg and 125 mg. Bosentan is marketed under the brand name Tracleer.
Oral Administration: Bosentan tablets should be taken twice daily, in the morning and evening, with or without food. It is important to take the medication at the same times each day to maintain consistent blood levels.
Monitoring: Patients should have their liver function and hemoglobin levels monitored regularly due to the risk of liver toxicity and anemia associated with Bosentan.
Typical Dosing
FDA Approved Indications
The typical dosage of Bosentan for adults starts with:
- Starting Dose: 62.5 mg taken orally twice daily for the first 4 weeks.
- Maintenance Dose: After 4 weeks, the dose is typically increased to 125 mg taken twice daily, depending on the patient's response and tolerability.
Who Shouldn't Take Bosentan?
Bosentan is contraindicated in patients with:
- Known hypersensitivity to Bosentan or any component of the formulation.
- Moderate to severe liver impairment or elevated liver enzymes (greater than 3 times the upper limit of normal).
- Pregnancy: Bosentan is contraindicated during pregnancy due to the risk of fetal harm. Women of childbearing potential must use effective contraception and undergo regular pregnancy testing while taking Bosentan.
Advice From The Pharmacist
Patients using Bosentan should be advised to:
- Take the medication exactly as prescribed and do not skip doses, as this can reduce its effectiveness in managing PAH.
- Regularly monitor liver function and hemoglobin levels as instructed by their healthcare provider, and report any symptoms such as unusual fatigue, jaundice, or dark urine, which could indicate liver problems.
- Use effective contraception to prevent pregnancy while taking Bosentan, and continue contraceptive use for at least one month after stopping the medication. Regular pregnancy tests are required for women of childbearing potential.
- Be aware of potential side effects, such as headaches, flushing, and leg swelling, and report any severe or persistent symptoms to their healthcare provider.
Side Effects of Bosentan
Common Side Effects
- Headache
- Flushing
- Leg or ankle swelling (edema)
- Nasal congestion
- Fatigue
- Low blood pressure (hypotension)
- Elevated liver enzymes
Uncommon/Severe Side Effects
- Liver toxicity: Bosentan can cause serious liver damage. Regular liver function tests are required, and patients should be monitored for signs of liver dysfunction, such as jaundice or dark urine.
- Anemia: Bosentan can decrease hemoglobin levels, leading to anemia. Regular blood tests are needed to monitor hemoglobin.
- Fetal harm: Bosentan is teratogenic and can cause birth defects if taken during pregnancy. Women must use effective contraception and undergo regular pregnancy tests.
Risks and Warnings of Bosentan
Liver Toxicity: Bosentan can cause serious liver damage, leading to liver failure in some cases. Liver function tests should be performed before starting treatment, monthly during treatment, and for one month after discontinuation.
Anemia: Bosentan can decrease hemoglobin levels, leading to anemia. Hemoglobin levels should be monitored before starting treatment, after one month, and periodically thereafter.
Pregnancy: Bosentan is contraindicated in pregnancy due to the risk of fetal harm. Women of childbearing potential must use effective contraception and have regular pregnancy tests while on the medication.
Interactions with Bosentan
Common Drug Interactions
Bosentan may interact with other medications, including:
- Cyclosporine: Concurrent use is contraindicated due to the risk of significant increases in Bosentan blood levels.
- Rifampin: May decrease the effectiveness of Bosentan by increasing its metabolism.
- Hormonal contraceptives: Bosentan may reduce the effectiveness of hormonal contraceptives. Additional forms of contraception are recommended.
- Warfarin: May interact with Bosentan, necessitating closer monitoring of blood coagulation parameters.
Patients should inform their healthcare provider of all medications and supplements they are taking to avoid potential interactions.
Alternatives to Bosentan
Alternative treatments for pulmonary arterial hypertension include:
- Other endothelin receptor antagonists (ERAs): Such as ambrisentan or macitentan.
- Phosphodiesterase-5 inhibitors: Such as sildenafil or tadalafil, which also help to relax blood vessels and reduce blood pressure in the lungs.
- Prostacyclin analogs: Such as epoprostenol, treprostinil, or iloprost, which dilate blood vessels and inhibit blood clotting in the lungs.
- Soluble guanylate cyclase stimulators: Such as riociguat, which help to widen the blood vessels in the lungs.
The choice of treatment depends on the specific condition, the severity of PAH, and the patient’s response to previous treatments.
